Actively Recruiting
Morphological and Functional Pilot Study of the Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2025-04-25
450
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Bronchiolitis obliterans (BO) is a rare, irreversible lung condition that causes blockage or closure of small airways, often developing in children after serious lower respiratory infections, mainly from adenovirus or rhinovirus. This study aims to understand the damage to the respiratory lining in children who develop post-infectious bronchiolitis obliterans (PIBO) compared to those who do not. Researchers hypothesize that the nasal lining's structure differs between these groups and seek to characterize these differences over time. The study involves children aged 1 month to 6 years hospitalized with adenovirus or rhinovirus infections, divided into two groups: those who develop PIBO and those who do not. At the start, all children will have nasal swabs and brushings. Children who develop PIBO will undergo additional procedures including nasal brushing, bronchial biopsies, and bronchoalveolar washing at diagnosis and again after six months if treatment response is partial. This observational study follows participants over an average of three years. Participants will be closely monitored through clinical assessments, nasal and bronchial tissue examinations, and laboratory analyses to evaluate inflammation, antiviral responses, and changes in respiratory epithelium. Researchers will study how the nasal and bronchial linings change over time in PIBO cases and analyze molecular profiles from biopsies. The main outcome is defining the extent of epithelial damage in PIBO, with ongoing evaluation of inflammatory and antiviral factors during the study period.
CONDITIONS
Brief Title
Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged from 1 month to 6 years hospitalized at the Timone Enfant University Hospital
- Diagnosis of adenovirus or rhinovirus respiratory infection confirmed by nasal swab upon arrival
- Parents have read, understood, and signed the consent form before any study procedures
- Affiliated to or beneficiary of a social security scheme
- Children aged 1 month to 6 years transferred to the Timone Enfant University Hospital
- Clinical signs persisting 6 weeks after viral infection such as rapid breathing, wheezing, and/or persistent low oxygen
- Scan showing mosaic pattern, bronchiectasis, or atelectasis
- If performed, lung function tests showing obstructive ventilatory disorder not or slightly reversible after bronchodilators
You will not qualify if you...
- Family refuses participation or lacks parental authority
- Presence of chronic lung diseases such as cystic fibrosis or ciliary dyskinesia
- Presence of coagulation or bleeding disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Through study completion, an average of 3 years
Participants undergo morphological and functional studies of the respiratory epithelium to assess differences related to adenovirus or rhinovirus infection and progression to PIBO.
Assessments occur as scheduled throughout the study period
Duration - Through study completion, an average of 3 years
Participants are followed over time to monitor the morphology of the nasal and bronchial epithelia and evaluate pro-inflammatory and antiviral mediators involved in disease progression.
Ongoing assessments during the study duration
Trial Site Locations
Total: 1 location
1
APHM
Marseille, France, 13000
Actively Recruiting
Research Team
J
Julie MAZENQ, PhD
D
Delphine Gras
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here